Cel
Investigation of the clinical prognostic value of soluble urokinase plasminogen activator receptor (uPAR) forms in blood and tissue extracts from patients with colon and breast cancer, aiming to develop new methods which will aid in the decision-making needed in the management of cancer patients.
Zaproszenie do składania wniosków
Data not availableSystem finansowania
RGI - Research grants (individual fellowships)Koordynator
2100 KOEPENHAGEN
Dania